Nuclear Medicine AtlasInteractive atlas

Thyroiditis

The low-uptake thyrotoxicosis, distinguishing it from Graves disease

Evidence B#endocrine#thyroidUpdated 2026-07-27 · Physician-reviewed
High-yield mode — key points, high-yield facts, tables & quizzes only. Toggle off for full text.

Quick Answer

Thyroiditis causes thyrotoxicosis by releasing preformed hormone from an inflamed, damaged gland — not by overproduction — so radioiodine uptake (RAIU) is low, the mirror image of Graves disease. Recognizing this pattern prevents inappropriate I-131: there is no trapping tissue to treat. Management is supportive (beta-blockade; NSAIDs/steroids for the painful subacute form) through an often triphasic course (thyrotoxic → hypothyroid → recovery). Always exclude a recent iodine load and exogenous thyroid hormone, which also produce low-uptake thyrotoxicosis.

Background & Pathophysiology

Thyroiditis is destructive/inflammatory thyroid injury that spills stored T4/T3 into the circulation. Because the follicular cells are damaged and TSH is suppressed, iodine trapping falls — hence low RAIU. The subtypes:

  • Subacute (de Quervain / granulomatous): often painful, post-viral, with elevated ESR/CRP; typically triphasic and self-limited.
  • Painless / silent (a variant of autoimmune thyroiditis) and postpartum thyroiditis: painless, antibody-associated, often triphasic.
  • Amiodarone-induced thyrotoxicosis type 2 (destructive; low uptake, low vascularity on Doppler) — contrast with type 1 (iodine-induced overproduction in nodular glands).
  • Hashimoto (chronic lymphocytic): usually hypothyroid, but can have an early hashitoxicosis phase.

Clinical & Laboratory

Thyrotoxic symptoms (palpitations, tremor, heat intolerance) identical to Graves, but without ophthalmopathy/pretibial myxedema. Labs: suppressed TSH, elevated free T4/T3; elevated ESR/CRP and tender gland in subacute; TPO antibodies in autoimmune forms; a low or normal thyroglobulin is expected in factitious (exogenous) thyrotoxicosis, distinguishing it from true thyroiditis.

Imaging Role

The RAIU / pertechnetate scan sorts the thyrotoxicosis differential:

Uptake Cause
Low/absent Thyroiditis, exogenous hormone, iodine load, struma ovarii (ectopic)
Diffusely increased Graves disease
Focal increased, suppressed background Toxic adenoma / toxic multinodular goiter

Color-flow Doppler complements uptake: low vascularity in destructive thyroiditis (and AIT type 2) vs the "thyroid inferno" hypervascularity of Graves.

Interpretation & Decision

A low RAIU in a thyrotoxic patient means the gland is leaking or loaded, not making — do not give I-131. Confirm there is no recent iodinated contrast/amiodarone/kelp, and consider exogenous hormone (check thyroglobulin — low in factitious). Anticipate the hypothyroid phase; most patients recover, though postpartum/silent forms may leave permanent hypothyroidism.

Differential Diagnosis

Graves disease (high uptake, orbitopathy), toxic nodular disease (focal uptake), exogenous/factitious thyrotoxicosis (low thyroglobulin), iodine-induced (Jod-Basedow), struma ovarii (pelvic uptake, absent neck uptake), and amiodarone type 1 vs type 2.

Reporting Checklist

  • State the RAIU value with timing/reference range and the scan pattern (low/absent).
  • Note Doppler vascularity if performed (low in destructive forms).
  • Explicitly flag that low uptake is not a radioiodine indication; recommend supportive management.
  • Document iodine-load/medication history.

Common Pitfalls

  • Treating thyroiditis as Graves — wasted, ineffective radioiodine.
  • Missing exogenous levothyroxine or iodine load as the cause of low-uptake thyrotoxicosis.
  • Overlooking the hypothyroid phase and stopping surveillance early.
  • Conflating amiodarone type 1 (iodine-induced, treat the overproduction) with type 2 (destructive, steroids).

Board Pearls

Thyroiditis causes thyrotoxicosis by releasing preformed hormone from an inflamed gland, not by overproduction — so RAIU is low, the mirror image of Graves. That single finding prevents inappropriate I-131 (nothing is trapping iodine to treat). Management is supportive (beta-blockade; NSAIDs/steroids for pain) through an often triphasic self-limited course.

Always exclude a recent iodine load and exogenous hormone, which also suppress uptake — check thyroglobulin (low in factitious/exogenous thyrotoxicosis). Doppler shows low vascularity in destructive thyroiditis vs the "thyroid inferno" of Graves.

Distinguish amiodarone-induced thyrotoxicosis type 2 (destructive, low uptake/low vascularity, steroid-responsive) from type 1 (iodine-induced overproduction in nodular glands). Consider struma ovarii when the neck uptake is absent but the patient is thyrotoxic (ectopic thyroid tissue concentrates iodine in the pelvis).

  • Tracer: Radioiodine (I-123/I-131); diseases: Hyperthyroidism, Thyroid nodule.

Figure / Diagram Suggestions

  • A low-uptake vs Graves diffuse-uptake teaching pair.
  • A triphasic thyroiditis timeline (thyrotoxic → hypothyroid → recovery).
  • A Doppler "low-flow destructive" vs "thyroid inferno" comparison.

Self-Check

Q1. Why is radioiodine uptake low in thyroiditis despite thyrotoxicosis?

Answer: The gland is releasing preformed stored hormone from inflammatory damage, not overproducing — trapping is suppressed, so RAIU is low.

Q2. A thyrotoxic patient has low RAIU. What two non-thyroiditis causes must you exclude?

Answer: Exogenous thyroid hormone (check low thyroglobulin) and a recent iodine load (contrast, amiodarone, kelp).

Q3. How does color-flow Doppler help separate destructive thyroiditis from Graves?

Answer: Destructive thyroiditis shows low vascularity; Graves shows hypervascular "thyroid inferno."

Q4. Distinguish amiodarone-induced thyrotoxicosis type 1 from type 2.

Answer: Type 1 = iodine-induced overproduction in nodular glands; Type 2 = destructive thyroiditis (low uptake/low vascularity, steroid-responsive).

Evidence & sources

BATA/AACE guidance — low radioiodine uptake distinguishes thyroiditis (and exogenous/iodine causes) from Graves disease in thyrotoxicosis.
Cite this page. Nuclear Medicine Atlas. “Thyroiditis.” v1.76, 2026-10-25. Permalink: https://nuc.med/thyroiditis/ Report an issue
Nuclear Medicine Atlas · v1.76 · built 2026-10-25Terms · Privacy · Disclaimer